Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Hated These Tech Stocks in Q1

Page 1 of 2

Like the broader US stock market, technology stocks fell sharply during the first six weeks of 2016. Compared to the S&P500 index, which fell by 9%, the Dow Jones U.S. Technology Index fell by as much as 12.7% by mid-February, creating good opportunities to buy tech stocks on the cheap. Nonetheless, not all tech stocks attracted fresh investments during the slump, as some tech stocks registered notable declines in hedge fund ownership, despite some of them suffering severe drops in valuation, which should have theoretically made them more attractive. In this article we’ll take a look at five tech stocks that greatly lost their appeal in the eyes of the top hedge fund managers tracked by Insider Monkey.

everything possible/Shutterstock.com

everything possible/Shutterstock.com

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).

Operating Margins and Hedge Fund Support Shrinking at Proofpoint

A 45% depreciation in Proofpoint Inc (NASDAQ:PFPT) shares early in 2016 prompted hedge funds to distance themselves from the provider of data protection services. Whereas at the end of December 2015, 30 top hedge funds held the stock in their portfolios, by the end of March that number had fallen to 22, or approximately 3% of the funds tracked by Insider Monkey. Proofpoint Inc (NASDAQ:PFPT)’s revenue has been on the rise for the past four quarters, reaching $79 million for the three months ended March 31, 2016. The company also posted a loss of $31.7 million for the first quarter, or $0.09 per share when adjusted for one-time gains and costs. The other side of the coin shows decreasing operating margins amid growing revenue and increased competition in the segment. Ken Griffin‘s Citadel Investment Group dumped nearly 70% of its stake in Proofpoint Inc (NASDAQ:PFPT) during the first quarter, ending March with only 96,444 shares worth $5.18 million.

Follow Proofpoint Inc (NASDAQ:PFPT)
Trade (NASDAQ:PFPT) Now!

Security Solutions Provider Leaking Hedge Fund Support

The number of top hedge funds invested in Lifelock Inc (NYSE:LOCK) fell by nearly 50% to 16 throughout the first quarter, with those funds’ ownership amounting to 16.2% of the company’s common stock. The provider of security solutions has been on a good run lately, having posted solid growth numbers for the first quarter. Revenue rose by 18% year-over-year to $159.3 million, while membership increased by 11% to 4.3 million. An increase in marketing efforts led to a larger net loss however, with Lifelock Inc (NYSE:LOCK) having posted a loss of $11.7 million, or $0.06 per share on an adjusted basis. The company’s weak forward guidance has also put pressure on the stock. Lifelock said it expects second quarter earnings to range between $0.03 and $0.04 per share. Steve Cohen liquidated his investment in Lifelock Inc (NYSE:LOCK) during the first quarter, with his fund Point72 Asset Management selling off all 129,300 shares of the tech company that it held on December 31.

Follow Lifelock Inc. (NYSE:LOCK)
Trade (NYSE:LOCK) Now!

Turn the page to find out which three tech stocks hedge funds hated the most in the first quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!